Stem Cell Therapy NG-01 Shows Neuroprotective Effects in Trial

NeuroGenesis Mesenchymal Stem Cell Therapy Shows Positive Impact on NfL in Phase 2 Progressive MS Study

NeuroGenesis and Hadassah Medical Center Report Positive NF-L Biomarker Results from a Phase 2 Study in Progressive Multiple Sclerosis Treated with NG-01 Cells Therapy

NeuroGenesis and Hadassah Medical Center Report Positive NF-L Biomarker Results from a Phase 2 Study in Progressive Multiple Sclerosis Treated with NG-01 Cells Therapy

Stem cell treatment ‘freezes’ MS, lets some walk again, Jerusalem study finds

Today's BioWorld: Israeli Neurogenesis’ NG-01 slows progressive MS by up to 90% in phase II study